Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
311.81
+2.69 (0.87%)
At close: Oct 6, 2025, 4:00 PM EDT
311.69
-0.12 (-0.04%)
After-hours: Oct 6, 2025, 4:00 PM EDT
Insulet Revenue
Insulet had revenue of $649.10M in the quarter ending June 30, 2025, with 32.88% growth. This brings the company's revenue in the last twelve months to $2.36B, up 25.99% year-over-year. In the year 2024, Insulet had annual revenue of $2.07B with 22.07% growth.
Revenue (ttm)
$2.36B
Revenue Growth
+25.99%
P/S Ratio
9.20
Revenue / Employee
$605,000
Employees
3,900
Market Cap
21.95B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.07B | 374.50M | 22.07% |
Dec 31, 2023 | 1.70B | 391.80M | 30.02% |
Dec 31, 2022 | 1.31B | 206.50M | 18.79% |
Dec 31, 2021 | 1.10B | 194.40M | 21.49% |
Dec 31, 2020 | 904.40M | 166.20M | 22.51% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
PODD News
- 14 days ago - These 15 stocks have beaten the S&P 500 this year — while getting cheaper in the process - Market Watch
- 18 days ago - Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette - Business Wire
- 20 days ago - Medical device maker Insulet names industry veteran Flavia Pease as CFO - Reuters
- 20 days ago - Insulet Announces CFO Transition - Business Wire
- 27 days ago - Insulet Corporation (PODD) Presents At Baird Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - Insulet Corporation (PODD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 5 weeks ago - Insulet Elevates Eric Benjamin to Chief Operating Officer - Business Wire
- 6 weeks ago - Insulet to Participate in Upcoming Investor Conferences - Business Wire